ici 118551 and Head and Neck Neoplasms

ici 118551 has been researched along with Head and Neck Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barbieri, A; Bimonte, S; Caraglia, M; Del Vecchio, V; Desiderio, V; Giudice, A; La Noce, M; Liccardo, D; Marampon, F; Mele, L; Mosca, L; Papaccio, G; Prisco, C; Regad, T; Schwerdtfeger, M; Tirino, V; Wagner, S	1

Other Studies

1 other study(ies) available for ici 118551 and Head and Neck Neoplasms

Article	Year
β Cell death & disease, 2020, 10-13, Volume: 11, Issue:10 Topics: Adrenergic beta-2 Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Drug Synergism; Head and Neck Neoplasms; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; NF-E2-Related Factor 2; Propanolamines; Protein Kinase Inhibitors; Receptors, Adrenergic, beta-2; Signal Transduction; Squamous Cell Carcinoma of Head and Neck	2020

Article

Year

Cell death & disease, 2020, 10-13, Volume: 11, Issue:10

Topics: Adrenergic beta-2 Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Drug Synergism; Head and Neck Neoplasms; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; NF-E2-Related Factor 2; Propanolamines; Protein Kinase Inhibitors; Receptors, Adrenergic, beta-2; Signal Transduction; Squamous Cell Carcinoma of Head and Neck

2020